Neumora Therapeutics, Inc. Share Price

Neumora Therapeutics, Inc. Share Price

NASDAQ: NMRA | Micro Cap
$0.40
+$0.01 (3.25%) Last updated on 29 Oct, 2026 | 19:50 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neumora Therapeutics, Inc. Stock Performance

Open
$0.39
Prev. Close
$0.39
Circuit Range
N/A
Day Range
$0.39 - $0.41
Year Range
$0.32 - $3.65
Volume
3,008
Average Traded
$0.40

Neumora Therapeutics, Inc. Share Price Today

As of 29 October 2026, Neumora Therapeutics, Inc.'s share price is $0.40. The stock opened at $0.39, compared to its previous close of $0.39. During today's trading session, Neumora Therapeutics, Inc.'s share price traded between $0.39 and $0.41, with an average price of $0.40. Over the past 52 weeks, the stock has recorded a high of $3.65 and a low of $0.32. In terms of performance, Neumora Therapeutics, Inc.'s share price has declined by 83.60% over the last six months and is down 86.55% on a year-on-year basis.

Neumora Therapeutics, Inc. Share Price Chart

Line chart of the Neumora Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 0.39 to 0.41, ending at 0.40.
$0.39$0.41
L
Show Current Price
H

Neumora Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$65.93M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-477.87%
Profit Margin
N/A
Debt to Equity
1.19
Quarterly Earnings Growth YoY
24.10%

Neumora Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$56.76-$59.45-$53.46-$43.08
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-4.74%10.08%19.42%

Neumora Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$235.93-$243.79-$236.93
Net Profit MarginN/AN/AN/A
Income ChangeN/A-3.33%2.81%

About Neumora Therapeutics, Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.61
$0.40
-33.72%
Sep 2026
$1.33
$0.61
-58.92%
Aug 2026
$1.62
$1.48
-8.07%
Jul 2026
$1.69
$1.61
-4.73%
Jun 2026
$1.85
$1.69
-8.65%
May 2026
$2.46
$1.85
-24.80%
Apr 2026
$1.99
$2.46
+26.48%
Mar 2026
$2.85
$1.95
-44.11%
Feb 2026
$2.05
$3.48
+74.87%
Jan 2026
$1.79
$1.99
+11.48%
Dec 2025
$2.50
$1.78
-20.31%
Nov 2025
$3.04
$2.24
-25.33%

NMRA Share Price FAQs